Introduction
The EU and US (EU Directive-2010/63/EU and US Public Law 106-545, 2010, 106th Congress) have put in place legislation for the protection of animals used for scientific research and fostered research on the development of alternative methods for toxicity and safety testing to address legislative requirements. In this context, Raman microspectroscopy is a promising technique for the in vitro investigation of cellular drug uptake and modes of action. [1] The lateral resolution of confocal Raman microspectroscopy, typically in the hundreds of nanometre to micrometre range, allows spatial characterisation of organelles in cells [2] . Besides, as water is a weak Raman scatterer, the method is ideal for use in the living environment of cells [3] . By monitoring the spectra of the different cellular regions (e.g. cytoplasm, nucleus and nucleolus) after drug inoculation, a large amount of molecular information of the cell can be obtained, including the presence of the drug as well as metabolic changes induced. [4, 5] Raman spectroscopy has been shown to be very efficient in monitoring the effect of the drug over time, which is essential to understand the drug mode (i.e. molecular targets of the drug) and mechanism of action (i.e. phenotypic changes induced by the drug). [6] By investigating the evolution of the Raman bands of the drug, the drug metabolites and the rest of the components, one can establish the composition ratio of the drug and the molecules which are affected by the drug. [7] [8] [9] [10] Different biomolecules (i.e. proteins, carbohydrates, nucleic acids and lipids), as well as drugs, can present highly overlapped Raman signatures and thus, the spectra can be used for extracting information about the drug uptake and the phenotypic responses induced by the drug. However, Raman data sets are complex and should be data mined using multivariate methods to extract biologically meaningful information. [11] Although in most of the cases the cell functional responses as well as drug metabolism and uptake are changing in a non-linear fashion with time, linear algorithms, such as Partial Least Squares Regression (PLSR), [12] are commonly used to model these effects. [13] [14] [15] This implies building a model in which the predicted Y is the time value, and then studying the contribution of the different variables (either negative or positive) to the linear model, as manifest in the regression vector. As an alternative, orthogonal partial least squares regression (OPLSR) is an extension of PLS which applies an orthogonal correction filter to extract spectral variations important to the prediction from the variations orthogonal to the time. [16] Although the performance of OPLSR models is generally largely equivalent to that provided by PLSR, OPLSR models gain in terms of interpretability of the variables, all the variance associated with Y being represented in the first latent variable (LV). Other methods to investigate these systems include two-dimensional [17] correlation analysis and Principal Component Analysis [18] .
Two main problems are anticipated when using PLSR based techniques for the investigation of the temporal evolution of responses associated with drug modes and mechanisms of action. Firstly, while the Raman signal is linear with the concentration of Raman active biochemical compounds, both drug uptake and cellular responses follow diverse non-linear kinetic patterns [19] . Secondly, the regression vector cannot decompose the spectral variations which occur at different rates, being unable to differentiate spectral changes associated with the drug from variations associated with the subsequent cellular response. This restricts the use of PLSR to different time ranges in order to capture different linear regions of the drug uptake and response. [20] Multivariate Curve Resolution -Alternating Least Squares (MCR-ALS) is used for resolving multiple component responses of unresolved mixtures, resolving the bilinear model by an alternative least squares iterative optimisation. [21] The bilinear model is defined as:
In which D (i × j) is the matrix of spectral data of i samples and j variables, and C (i × n) is the concentration matrix containing the concentrations of the N components of the system for each spectrum. S T (n × j) is the transpose of the spectra of the pure components and E (i x j) is the residual matrix. When a temporal evolution is considered, MCR-ALS extracts: i) the concentration C matrix of the components over i time points and ii) the pure spectrum of each component on the matrix S. The former matrix is useful for studying the kinetics of the process and the latter to assign the bimolecular aetiology of each component. This technique is extremely useful in monitoring changes in complex and potentially non-linear temporal evolutions of multicomponent systems such as biological ones. It is also based on a bilinear model of Raman intensities and concentration of components in a sample. However, MCR-ALS decomposes the spectral data matrix for a selected number of pure component spectra and concentration vectors. The concentration profiles can follow non-linear dependences with time, as defined by multiple kinetic equations.
In this work, using simulated and real data, we evaluate the use of MCR-ALS to decompose the Raman spectra of cells upon inoculation of a drug, to establish a kinetic model of the drug uptake, and cellular responses. First, we used Ordinary differential Equations (ODE) to simulate drug uptake and 2 subsequent response curves, which were added as time dependent perturbations to control cellular spectra, creating a dataset containing 36 simulated [20] . The predicted concentrations map out the drug uptake and cellular response curves. The technique shows great potential to investigate non-linear kinetics and modes of action.
Materials and Methods
Here, we provide a summary of the materials and methods used for the experimental data. Further information can be accessed in the original publications [17, 20] .
Cell culture and inoculation
A549 cells were cultured in DMEM-F12 with 10% fetal bovine serum (FBS) and Calu-1 cells in RPMI with 10%
FBS, both at 37°C in a humidified atmosphere containing 5% CO2 and cells were split every two days to maintain ~60% confluency.
Cells (~ 1x 10 4 /window) were seeded and incubated on CaF2 windows (Crystan Ltd, UK) for 24 h for both control and exposure to DOX. The medium was then removed and samples were rinsed twice with sterile PBS and covered with DOX at the corresponding IC50 inhibitory concentration, adjusted to the cell number [20] . After each incubation period, 2, 6, 12, 24, 48 and 72 h, cells were washed twice with sterile PBS and fixed in formalin (4%,
min).[22]

Raman Spectroscopy
A Horiba Jobin-Yvon LabRAM HR800 spectrometer with a 785 nm, 300 mW diode laser as source, Peltier cooled 16-bit CCD, 300 lines/mm grating and 100 μm confocal hole, was used for this work. Spectra were acquired in the range from 400 cm -1 to 1800 cm -1 using a x100 objective (LCPlanN, Olympus), in dry conditions, for 30s two times, from three cell locations: cytoplasm, nucleus and nucleolus, visible under white light illumination. A final data set of 30 spectra per cell location for each time point, 2, 6, 12, 24, 48 and 72 h was produced after DOX exposure and for control cells, for each cell line, amounting to a total of over 210 cells per cell line, corresponding to a total data set of 1260 spectra. For the purpose of this study, data from the nucleolus only were considered.
Data Simulation
Experimental control spectra were derived from the study of Farhane et al. [20] , measured as described above, and the 30 nucleolar spectra averaged. Based on the results of the PLSR analysis of the original study, simulated early (Response 1) and late (Response 2) spectral response profiles were generated in the Horiba Labspec 5 software, as described in Byrne et al. [17] The temporal evolution of the respective contributions of the simulated responses were derived according to the rate equations described in the "Results Section". Simulated datasets were created by adding weighted sums of the responses to the control spectra using the Matlab 2019a platform (Mathworks, Natick, MA, USA).
Data Analysis
Data Treatment and data analysis is available at the Zenodo repository (10.5281/zenodo.3339285). Data analysis was performed using MATLAB 2019a from Mathworks (Natick, MA, USA). MCR-ALS was performed using the Graphical user interface available at https://mcrals.wordpress.com/. [23, 24] Non negativity constrains were used for both spectra and concentrations. Considering the absence of maxima and minima in the concentration profiles, a unimodality constraint was also applied to the concentration. Pure spectra were normalised using the total sum (i.e. Each spectrum was divided by the total sum of the spectra). This step ensured that all the pure spectra computed were in a similar range. A maximum of 50 iterations were considered, employing a tolerance sigma value of 0.1. The initial estimations of the concentrations were obtained using those column profiles from the original data matrix which were numerically most different. The number of components tested varied from 2 to 3, depending on the Single Value Decomposition analysis performed prior to the MCR-ALS. Two kinds of MCR-ALS models were considered: without equality constraints and with equality constraints involving one component. In the latter case, the pure spectrum was forced to be the initial spectrum (InC) and the concentration was fixed to 1 for all the time points. Firstly, MCR-ALS was used without any equality constraint. If the model provided results with rotational ambiguity, the constraint was introduced.
OPLSR models were calculated using the PLS_Toolbox 8.6 from Eigenvector Res. Inc. (Manson, WA, USA).
Standard Normal Variate (SNV) and mean centring was used for spectral pre-processing. Model complexity (i.e. number of LVs) was selected as the smallest number for which a decrease in the RMSECV between consecutive LVs was less than 3%.
Results
Simulation of spectral responses of cells under different scenarios
Simulations were based on previous works by Farhane et al. [20] and Byrne et al [17] , which identified spectral The effects of drug uptake after inoculation on a cell, described by the intensity of Responses 1 and 2, can be simulated considering ordinary differential equations [17] . , the number of DOX molecules bound to DNA and , the intensity of the subsequent cellular response as a function of time can be expressed as:
Where and describe the drug uptake and response rates, respectively (2.5 × 10 −4 and 2.5 × 10 −6 h -1 in this study), D is the drug dose, is the number of receptors in the nucleolus and is a parameter to limit the number of responses. To simulate the measured cellular responses, the spectral responses, weighted according to their temporal evolution, can be added to a measured, control dataset.
In this study, the use of MCR-ALS to different scenarios in which the phenotype of a cell is disrupted by an external agent was evaluated in simulated spectral data sets using the profiles calculated from equations (1) and (2) (see Figure 2a ), and considering extrinsic perturbations with and without identifiable Raman spectral signatures as well as additive and subtractive spectral contributions.
Dataset I. Undetectable perturbation, subtractive response 1 and additive response 2.
This dataset simulates the effect of a perturbing factor which does not have its own a characteristic Raman spectrum, as is the case, for example, for ionising or non-ionising radiation, or a drug or toxicant which does not have a strong Raman signature at the dose applied [25] . The presence of this perturbation provokes a synchronous alteration of the cellular composition (i.e. Response 1, e.g. DNA damage) that triggers a subsequent molecular response of the cell (Response 2). Such a response can be simulated according to equation 4:
S1 (t) = IC -SR1IR1(t) + SR2IR2(t) + N (4)
Where IC is the initial component (i.e. Raman spectrum of the cell without the drug), SR1 and SR2 are the simulated spectra of the Responses 1 and 2, respectively and IR1 (t) and IR2 (t) are the simulated intensity profiles of Responses 1 and 2, respectively. N is Gaussian noise, computed as the 0.1 % of the length (maximum of the dataset minus minimum of the dataset) of the spectra ).
The simulated data set is depicted in Figure 1 
Concentration profiles on a) and c) have been normalised to the range [0 1]. Spectra in b) and d) have been
shifted on the y axis for clarity.
Dataset II. Detectable disruption, additive response 1 and additive response 2.
Dataset II simulates the effect of a Raman active perturbation factor, such as a drug or particle with a concentration above the limit of detection. Its subcellular interaction provokes a simultaneous Response 1, which represents the binding of the molecule or particle to the molecules of the cell and a subsequent phenotypic response of the cell (Response 2). Dataset II was simulated according to equation 5: (5) in which SDrug and IDrug are the spectra and concentration profile of the perturbing agent, in this case the drug spectrum and its dynamic uptake, respectively. Here, we assumed a negligible concentration of free drug compared to the bound drug, and that the drug uptake and Response 1 occur simultaneously. Also, in this case we also changed the sign of Response 1 to explore the use of MCR-ALS under additive conditions (i.e. the perturbative interaction resulted in an increase in the contribution of constituent cellular components). A visual inspection of the spectra of dataset II (Figure 1 As expected, MCR-ALS was not able to resolve the simulated drug internalisation and cellular response as two independent components, because both processes are synchronous. If they had different kinetics, it would have been possible to use the known DOX spectra as a pure spectrum to help resolve the system. Nonetheless, the MCR-ALS estimated concentration profiles obtained, depicted in Figure 3c , are highly correlated with the intensity profiles employed for the simulation (Figure 3a ). In this case, the profile corresponding to the first MCR-ALS component, which represented the simultaneous uptake of drug and cell response increased over time.
S2(t)= IC + SDrugIDrug(t) + SR1IR1(t) + SR2IR2(t) + N
Analysis by OPLSR (see Figure 3e and f) revealed again the lack of the linearity of the spectra and time. Although the first loading appropriately indicated an increase of DOX, Response 1 and Response 2 bands, MCR-ALS provided a more accurate description of the different non-linear spectral variations in the dataset over time. Data III simulates specifically the in vitro inoculation of A549 cells with DOX. In this case, the perturbing effect is a resonant drug and therefore its signal is comparable or significantly more intense than the signal associated with the drug bonding (Response 1) and subsequent cellular metabolic reaction (Response 2). The representative, Dataset III can be simulated according to:
S3(t)= IC + F SDrugIDrug(t) -SR1IR1(t) + SR2IR2(t) + N (6)
where F is a factor which increases the signal of the drug relatively to the signal of Response 1 and Response 2.
In this study F=8 was selected to match the values observed in the real dataset. Here, Response 1 was negative, again to simulate the experimentally observed spectral signature of the drug bonding to RNA/DNA in the nucleolus of the cell. For dataset III, the concentration profile indicated a signal increase, similar to the simulated DOX uptake (see 
Experimental DOX Dataset
The experimental DOX dataset, previously described by Farhane et al. [18] , was analysed using MCR-ALS and OPLSR under the conditions described on the "Data Analysis" section. Figure 1 The ambiguity found when three components were employed confirms that the secondary cellular response, expected to be similar to the simulated Response 2, was not identified in the real dataset. Nevertheless, it has to be noted that the real dataset included only spectra collected at 7 time points, and this limited temporal resolution hampered the resolution of complex cellular signatures. In order to study this, a further simulation experiment with the Dataset III was performed in which MCR-ALS models from simulated data with different levels of noise and number of time points were simulated. Figure 6 shows the similarity between the Response 2 spectral signature and the MCR-ALS component calculated as the correlation coefficient, over different temporal resolutions and noise levels. Results showed that, regardless the noise level, the quality of the resolved concentration and spectral profiles improves with the number of time points.
In summary, the results indicate that MCR-ALS outperforms the OPLSR method in extracting kinetic information as well as spectral markers of the different processes involved. On the other hand, in a recent study using the same experimental data and simulation approach, the use of a two dimensional correlation analysis [17] method was also able to determine that bands associated with Response 1 and Response 2 are asynchronous (i.e. they occurred at different rates). It did it also for the real dataset, while in this study MCR-ALS was not able to detect the Response 2, probably because the poor spatial resolution of the experimental data. However, compared to 2D correlation, MCR-ALS was able to provide the concentration profiles over time, which are extremely useful for the study of the kinetics involved on the drug uptake and cellular response. by the MCR-ALS for datasets simulated using different amount of noise and temporal resolution.
Conclusions
Results indicated that MCR-ALS is a usefully method for investigating the temporal evolution of drug uptake and cellular responses in cells in vitro. It outperforms OPLSR, as it provides kinetic information from different components that can evolve according to different non-linear time profiles. Dataset I indicated that additive and subtractive perturbations of the constituent cellular components can be identified in the concentration profiles and pure spectra profiles. Dataset II showed that simultaneous changes in molecules appear integrated as a single component, the use of molecular information (e.g. prior knowledge about the location of drug bands) being necessary to differentiate contributions of different species. Dataset III indicated that, if a component represents both, additive and subtractive contributions, the spectrum calculated by MCR-ALS will contain positive bands and nodes respectively.
MCR-ALS applied to real data from DOX inoculations in A549 cells extracted a component representing the drug uptake as well as the binding to DNA and RNA molecules. The dataset was limited in terms of temporal resolution, which hampered the extraction of the subsequent, longer term cellular responses. In summary, the application of MCR-ALS to decompose time series of Raman spectra after drug inoculation extracted significant information about changes on cell composition induced by the presence of the drug. This could be applied in the investigation of drug kinetics and modes of action and could be regarded as a revolutionary technique in preclinical screening to improving drug effectivity and investigate drug resistance.
